Loading
A hospital in Sfax, in southern Tunisia, whose radiotherapy department has two linear accelerators, a cobalt unit and two brachytherapy units. It is a site for an international breast cancer trial.
IAEA DIRAC's equipment report, read on 11 November 2026 with the entry last updated in 2024, lists Habib Bourguiba Hospital in Sfax with two linear accelerators, one cobalt-60 unit, two brachytherapy units and a CT scanner. ClinicalTrials.gov lists Habib Bourguiba Hospital, Sfax, as a site of the trial of inavolisib with pertuzumab and trastuzumab in PIK3CA-mutated HER2-positive breast cancer (NCT05894239). OnCo could not read a site of the hospital's own.
Shares A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer, Institut Salah Azaïez, Breast cancer (all types).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/